Top Banner

Click here to load reader

Pharmacy Show April Newspaper

Mar 28, 2016



Pharmacy Show April Newspaper

  • And, with a packed programme of clinical education and CPD also planned, this years show is the perfect opportunity for contractors to hone their pharmaceutical care skills. PSNC has told contractors: A quality conversation between the patient and the pharmacist is the most important element of the [NMS] consultation. This requires a two way discussion between the patient and the pharmacist, rather than the pharmacist delivering information in a didactic manner to a passive patient.

    Show director Matthew Butler said: With its packed schedule of conferences and education, the Pharmacy Show looks set yet again to become the must-attend event in the pharmacy calendar. We are delighted to be playing our part as hosts to the key players and mentors in community pharmacy service delivery at this crucial time for contractors.

    Extended funding for the community pharmacy New Medicine Service (NMS), announced by PSNC in mid-March, will allow

    pharmacies in England to recruit new patients to the service up until September 30th and to receive payment for these patients even where the service is completed in October or November 2013.

    To fund the extension of the NMS until September, PSNC has secured a further 20 million in funding. This takes the additional contract funding secured by PSNC for the NMS to 130m since the service was first announced in 2011.

    PSNC says the decision to extend the NMS after September 2013 lies with the emerging NHS Commissioning Board and that this will take into account any emerging data from the Department of Health (DH) commissioned evaluation of the service. This is currently due to report in September, but may be extended to ensure that enough patients are recruited to it.

    The NMS was originally commissioned until the end of March 2013 and in its first twelve months, the service was delivered to more than half a million English patients. @pharmacyshow April 2013

    SEE PAGE 2

    Cost and inconvenience influence repeat medication adherence


    PSNC updates contractors on NHS transition

    Floor plan and full exhibitor list

    This years Pharmacy Show, scheduled to take place on Sunday 29th - Monday, September 30th, 2013, at the National Exhibition Centre (NEC), Birmingham, will provide the perfect venue for contractors to discuss the future of pharmacy medicines optimisation services, and in particular the New Medicine Service, whose future after September, 2013 remains in the balance.


    New pharmacy funding arrangements effective from April 13 improve practice and advance funding payments, PSNC has said in a funding update that also reveals that that the Department of Health is considering a rethink of the current margins survey-based system. Noting the Departments preference for a more transparent system where all NHS earnings are accounted for, PSNC warns that the revised arrangements are being considered as part of the on-going Cost of Service Inquiry update negotiations.

    Sweetener deal for pharmacies as funding negotiations continue

    The Pharmacy Show won the event industrys most coveted award Best Trade Show at the annual Exhibition News Awards on April 10th.

    Register your interest in attending the 2013 Pharmacy

    Supported by Media partners

    Continued on page 2Continued on page 3

    By Ailsa Colquohon, Chief Correspondent

    By a Pharmacy Show Correspondent

    The shows marketing manager Lucy Pitt (Best Event Marketer) and Garry Tyson (Rising Star) also scooped awards on a glittering night for the Pharmacy Show team.


    Boots UK opened its new distribution centre in February 2012, investing over 50 million in the facility; this included the purchase of the existing 460,000 sq ft building the area of six football pitches its total refurbishment and the automated handling systems. The building accommodates the retailers e-commerce fulfilment operation, its Christmas gift operations and its growing international retail distribution, using a multichannel system designed and installed by KNAPP.

    Automated shuttle storageAt the heart of the solution are 12 of KNAPPs OSR Shuttle systems, which provide automated storage combined with goods-to-person order picking at eight ergonomically designed Pick-it-Easy workstations. KNAPP also supplied its own warehouse management and control systems to optimise

    all warehouse movements and processes. In addition, Boots contracted KNAPP to provide a team of resident engineers in order to maintain the handling solution. The system has increased time efficiency by 65% compared to the previous manual operation, while also improving order traceability and providing a significant reduction in variable costs. Expertise in pharma wholesaleKNAPPs client base in the pharmaceutical wholesale sector is impressive, with successful solutions supplied to The Co-operative Pharmacy, Celesio, Phoenix, Alliance and Sangers in the UK, as well as many leading international brands including Anzag in Germany; Aragofar and Hefagra in Spain; Medlog in Portugal; and Multipharma in Belgium. KNAPP clients in other industries include John Lewis, British Gas, Clarks, Avon Cosmetics, Bausch + Lomb, Coca-Cola, LOreal and Sony.

    Continued from page 1

    Analysis by PSNC of a sample of 224,000 patients receiving the NMS by October 2012 found that:

    31.9% of non-adherent patients became adherent to 31.5% of their medicines after the NMS intervention

    Pharmacists gave 366,702 pieces of healthy living advice to patients while they provided the service

    54.4% of NMS interventions were provided for patients prescribed medicines for hypertension, with 26.4% asthma/COPD, 11.3% diabetes and 7.9% anticoagulants/antiplatelet medicines

    Patients on asthma and COPD medicines had the lowest incidence of side-effects, but those side- effects caused non-adherence at nearly twice the rate than in the other disease states

    99.6% of NMS patients were recruited directly by pharmacies, with the remainder referred by GP practices.

    Welcoming the extension of the NMS, Sue Sharpe, PSNC chief executive, said: This funding, which represents additional money outside of core contract funding, will be welcome for contractors. All negotiations are difficult at the moment and PSNC worked very hard to make the case to the DH and the NHS CB for the continuation of the NMS. The positive conclusions we were able to draw from our analysis provided the main evidence base for use by DH and the Board in their decision on re-commissioning the service. While this analysis will only be one factor in the NHS CBs decision about the long-term future of the NMS, we are hopeful that the DH-commissioned evaluation will reflect our results.

    Isle of Wight contractor and PSNC Service Development Subcommittee member Gary Warner added: Ongoing widespread provision of the service is vital to demonstrate pharmacys commitment to supporting medicines optimisation. We will be doing all that we can to ensure that the service is able to continue

    beyond September, but the NHS CB will also want to see contractors continued commitment to providing the service to all eligible patients to deliver the maximum benefit for individuals and the NHS.

    The Pharmacy Show is organised by CloserStill Media Healthcare LimitedGeorge House, Coventry Business Park, Herald Avenue, Coventry CV5 6UB. Tel: 02476 717151

    Matthew Butler, Group Event Director [email protected] Beal, Show Manager [email protected] Tyson, Sales Executive [email protected] Pitt, Group Marketing Manager [email protected] Hulse, Marketing Executive [email protected] Danmeri, Head of Operations [email protected] Jackson, Conference & Speaker Manager [email protected] Wilson, Credit Controller [email protected] Slater, Event Administrator [email protected] Westcott, Managing Director [email protected]

    In a new report, Paying the Price. Prescription Charges and People with Long-Term Conditions, the Prescription Charges Coalition, says: 28-day prescribing may be costing more to both the NHS and the individual. Numerous initiatives to reduce medicine waste and improve the use of medicines have not addressed the impact of charges.

    The report urges prescribers to think about a patients exemption status when deciding the prescription duration. The report concludes: For stable, long-term conditions, three or six monthly prescribing may be the best approach. This will enable people to get on with their life while managing their condition and reduces the cost of unnecessary appointments.

    The report was issued as England raises prescription charges by 20p to 7.85 on April 1.

    In new advice from the BMA on avoiding excessive prescribing, GPs have been told that prescribing intervals should be in line with the medically appropriate needs of the patient, taking into account the need to safeguard NHS resources, patient convenience, and the dangers of excess drugs in the home.

    The GP guidance also cites a review of prescribing durations that recognises that shorter prescriptions are associated with significant increases in dispensing and other transaction costs, together with reductions in compliance in previously stable patients, and an increase in dissatisfaction amongst patients because of travel costs and time to obtain regular medicines. This review also states that shorter duration prescribing can place significant and unnecessary workload on the doctor and s